1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Geriatric Medicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analgesics 1.2.3 Antihypertensives 1.2.4 Statins 1.2.5 Antidiabetics 1.2.6 Proton Pump Inhibitor 1.2.7 Anticoagulant 1.2.8 Antipsychotics 1.2.9 Antidepressants 1.3 Market by Application 1.3.1 Global Geriatric Medicines Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cardiovascular diseases 1.3.3 Arthritis 1.3.4 Neurological Disorders 1.3.5 Cancer 1.3.6 Osteoporosis 1.3.7 Respiratory 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Geriatric Medicines Market Perspective (2016-2027) 2.2 Geriatric Medicines Growth Trends by Regions 2.2.1 Geriatric Medicines Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Geriatric Medicines Historic Market Share by Regions (2016-2021) 2.2.3 Geriatric Medicines Forecasted Market Size by Regions (2022-2027) 2.3 Geriatric Medicines Industry Dynamic 2.3.1 Geriatric Medicines Market Trends 2.3.2 Geriatric Medicines Market Drivers 2.3.3 Geriatric Medicines Market Challenges 2.3.4 Geriatric Medicines Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Geriatric Medicines Players by Revenue 3.1.1 Global Top Geriatric Medicines Players by Revenue (2016-2021) 3.1.2 Global Geriatric Medicines Revenue Market Share by Players (2016-2021) 3.2 Global Geriatric Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Geriatric Medicines Revenue 3.4 Global Geriatric Medicines Market Concentration Ratio 3.4.1 Global Geriatric Medicines Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicines Revenue in 2020 3.5 Geriatric Medicines Key Players Head office and Area Served 3.6 Key Players Geriatric Medicines Product Solution and Service 3.7 Date of Enter into Geriatric Medicines Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Geriatric Medicines Breakdown Data by Type 4.1 Global Geriatric Medicines Historic Market Size by Type (2016-2021) 4.2 Global Geriatric Medicines Forecasted Market Size by Type (2022-2027) 5 Geriatric Medicines Breakdown Data by Application 5.1 Global Geriatric Medicines Historic Market Size by Application (2016-2021) 5.2 Global Geriatric Medicines Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Geriatric Medicines Market Size (2016-2027) 6.2 North America Geriatric Medicines Market Size by Type 6.2.1 North America Geriatric Medicines Market Size by Type (2016-2021) 6.2.2 North America Geriatric Medicines Market Size by Type (2022-2027) 6.2.3 North America Geriatric Medicines Market Size by Type (2016-2027) 6.3 North America Geriatric Medicines Market Size by Application 6.3.1 North America Geriatric Medicines Market Size by Application (2016-2021) 6.3.2 North America Geriatric Medicines Market Size by Application (2022-2027) 6.3.3 North America Geriatric Medicines Market Size by Application (2016-2027) 6.4 North America Geriatric Medicines Market Size by Country 6.4.1 North America Geriatric Medicines Market Size by Country (2016-2021) 6.4.2 North America Geriatric Medicines Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Geriatric Medicines Market Size (2016-2027) 7.2 Europe Geriatric Medicines Market Size by Type 7.2.1 Europe Geriatric Medicines Market Size by Type (2016-2021) 7.2.2 Europe Geriatric Medicines Market Size by Type (2022-2027) 7.2.3 Europe Geriatric Medicines Market Size by Type (2016-2027) 7.3 Europe Geriatric Medicines Market Size by Application 7.3.1 Europe Geriatric Medicines Market Size by Application (2016-2021) 7.3.2 Europe Geriatric Medicines Market Size by Application (2022-2027) 7.3.3 Europe Geriatric Medicines Market Size by Application (2016-2027) 7.4 Europe Geriatric Medicines Market Size by Country 7.4.1 Europe Geriatric Medicines Market Size by Country (2016-2021) 7.4.2 Europe Geriatric Medicines Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Geriatric Medicines Market Size (2016-2027) 8.2 Asia-Pacific Geriatric Medicines Market Size by Type 8.2.1 Asia-Pacific Geriatric Medicines Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Geriatric Medicines Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Geriatric Medicines Market Size by Type (2016-2027) 8.3 Asia-Pacific Geriatric Medicines Market Size by Application 8.3.1 Asia-Pacific Geriatric Medicines Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Geriatric Medicines Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Geriatric Medicines Market Size by Application (2016-2027) 8.4 Asia-Pacific Geriatric Medicines Market Size by Region 8.4.1 Asia-Pacific Geriatric Medicines Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Geriatric Medicines Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Geriatric Medicines Market Size (2016-2027) 9.2 Latin America Geriatric Medicines Market Size by Type 9.2.1 Latin America Geriatric Medicines Market Size by Type (2016-2021) 9.2.2 Latin America Geriatric Medicines Market Size by Type (2022-2027) 9.2.3 Latin America Geriatric Medicines Market Size by Type (2016-2027) 9.3 Latin America Geriatric Medicines Market Size by Application 9.3.1 Latin America Geriatric Medicines Market Size by Application (2016-2021) 9.3.2 Latin America Geriatric Medicines Market Size by Application (2022-2027) 9.3.3 Latin America Geriatric Medicines Market Size by Application (2016-2027) 9.4 Latin America Geriatric Medicines Market Size by Country 9.4.1 Latin America Geriatric Medicines Market Size by Country (2016-2021) 9.4.2 Latin America Geriatric Medicines Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Geriatric Medicines Market Size (2016-2027) 10.2 Middle East & Africa Geriatric Medicines Market Size by Type 10.2.1 Middle East & Africa Geriatric Medicines Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Geriatric Medicines Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Geriatric Medicines Market Size by Type (2016-2027) 10.3 Middle East & Africa Geriatric Medicines Market Size by Application 10.3.1 Middle East & Africa Geriatric Medicines Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Geriatric Medicines Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Geriatric Medicines Market Size by Application (2016-2027) 10.4 Middle East & Africa Geriatric Medicines Market Size by Country 10.4.1 Middle East & Africa Geriatric Medicines Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Geriatric Medicines Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Eli Lilly and Company 11.1.1 Eli Lilly and Company Company Details 11.1.2 Eli Lilly and Company Business Overview 11.1.3 Eli Lilly and Company Geriatric Medicines Introduction 11.1.4 Eli Lilly and Company Revenue in Geriatric Medicines Business (2016-2021) 11.1.5 Eli Lilly and Company Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Geriatric Medicines Introduction 11.2.4 AstraZeneca Revenue in Geriatric Medicines Business (2016-2021) 11.2.5 AstraZeneca Recent Development 11.3 Boehringer Ingelheim 11.3.1 Boehringer Ingelheim Company Details 11.3.2 Boehringer Ingelheim Business Overview 11.3.3 Boehringer Ingelheim Geriatric Medicines Introduction 11.3.4 Boehringer Ingelheim Revenue in Geriatric Medicines Business (2016-2021) 11.3.5 Boehringer Ingelheim Recent Development 11.4 Abbott Laboratories 11.4.1 Abbott Laboratories Company Details 11.4.2 Abbott Laboratories Business Overview 11.4.3 Abbott Laboratories Geriatric Medicines Introduction 11.4.4 Abbott Laboratories Revenue in Geriatric Medicines Business (2016-2021) 11.4.5 Abbott Laboratories Recent Development 11.5 Sanofi 11.5.1 Sanofi Company Details 11.5.2 Sanofi Business Overview 11.5.3 Sanofi Geriatric Medicines Introduction 11.5.4 Sanofi Revenue in Geriatric Medicines Business (2016-2021) 11.5.5 Sanofi Recent Development 11.6 Bristol-Myers Squibb 11.6.1 Bristol-Myers Squibb Company Details 11.6.2 Bristol-Myers Squibb Business Overview 11.6.3 Bristol-Myers Squibb Geriatric Medicines Introduction 11.6.4 Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2016-2021) 11.6.5 Bristol-Myers Squibb Recent Development 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck Geriatric Medicines Introduction 11.7.4 Merck Revenue in Geriatric Medicines Business (2016-2021) 11.7.5 Merck Recent Development 11.8 Novartis 11.8.1 Novartis Company Details 11.8.2 Novartis Business Overview 11.8.3 Novartis Geriatric Medicines Introduction 11.8.4 Novartis Revenue in Geriatric Medicines Business (2016-2021) 11.8.5 Novartis Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Details 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Geriatric Medicines Introduction 11.9.4 Pfizer Revenue in Geriatric Medicines Business (2016-2021) 11.9.5 Pfizer Recent Development 11.10 GSK 11.10.1 GSK Company Details 11.10.2 GSK Business Overview 11.10.3 GSK Geriatric Medicines Introduction 11.10.4 GSK Revenue in Geriatric Medicines Business (2016-2021) 11.10.5 GSK Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Geriatric Medicines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Analgesics Table 3. Key Players of Antihypertensives Table 4. Key Players of Statins Table 5. Key Players of Antidiabetics Table 6. Key Players of Proton Pump Inhibitor Table 7. Key Players of Anticoagulant Table 8. Key Players of Antipsychotics Table 9. Key Players of Antidepressants Table 10. Global Geriatric Medicines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Geriatric Medicines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Geriatric Medicines Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Geriatric Medicines Market Share by Regions (2016-2021) Table 14. Global Geriatric Medicines Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Geriatric Medicines Market Share by Regions (2022-2027) Table 16. Geriatric Medicines Market Trends Table 17. Geriatric Medicines Market Drivers Table 18. Geriatric Medicines Market Challenges Table 19. Geriatric Medicines Market Restraints Table 20. Global Geriatric Medicines Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Geriatric Medicines Market Share by Players (2016-2021) Table 22. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicines as of 2020) Table 23. Ranking of Global Top Geriatric Medicines Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Geriatric Medicines Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Geriatric Medicines Product Solution and Service Table 27. Date of Enter into Geriatric Medicines Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Geriatric Medicines Market Size by Type (2016-2021) (US$ Million) Table 30. Global Geriatric Medicines Revenue Market Share by Type (2016-2021) Table 31. Global Geriatric Medicines Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Geriatric Medicines Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Geriatric Medicines Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Geriatric Medicines Revenue Market Share by Application (2016-2021) Table 35. Global Geriatric Medicines Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Geriatric Medicines Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Geriatric Medicines Market Size by Type (2016-2021) (US$ Million) Table 38. North America Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Geriatric Medicines Market Size by Application (2016-2021) (US$ Million) Table 40. North America Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Geriatric Medicines Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Geriatric Medicines Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Geriatric Medicines Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Geriatric Medicines Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Geriatric Medicines Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Geriatric Medicines Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Geriatric Medicines Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Geriatric Medicines Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Geriatric Medicines Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Geriatric Medicines Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Geriatric Medicines Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Geriatric Medicines Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Geriatric Medicines Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Geriatric Medicines Market Size by Country (2022-2027) & (US$ Million) Table 67. Eli Lilly and Company Company Details Table 68. Eli Lilly and Company Business Overview Table 69. Eli Lilly and Company Geriatric Medicines Product Table 70. Eli Lilly and Company Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 71. Eli Lilly and Company Recent Development Table 72. AstraZeneca Company Details Table 73. AstraZeneca Business Overview Table 74. AstraZeneca Geriatric Medicines Product Table 75. AstraZeneca Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 76. AstraZeneca Recent Development Table 77. Boehringer Ingelheim Company Details Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Geriatric Medicines Product Table 80. Boehringer Ingelheim Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 81. Boehringer Ingelheim Recent Development Table 82. Abbott Laboratories Company Details Table 83. Abbott Laboratories Business Overview Table 84. Abbott Laboratories Geriatric Medicines Product Table 85. Abbott Laboratories Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 86. Abbott Laboratories Recent Development Table 87. Sanofi Company Details Table 88. Sanofi Business Overview Table 89. Sanofi Geriatric Medicines Product Table 90. Sanofi Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 91. Sanofi Recent Development Table 92. Bristol-Myers Squibb Company Details Table 93. Bristol-Myers Squibb Business Overview Table 94. Bristol-Myers Squibb Geriatric Medicines Product Table 95. Bristol-Myers Squibb Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 96. Bristol-Myers Squibb Recent Development Table 97. Merck Company Details Table 98. Merck Business Overview Table 99. Merck Geriatric Medicines Product Table 100. Merck Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 101. Merck Recent Development Table 102. Novartis Company Details Table 103. Novartis Business Overview Table 104. Novartis Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 105. Novartis Recent Development Table 106. Pfizer Company Details Table 107. Pfizer Business Overview Table 108. Pfizer Geriatric Medicines Product Table 109. Pfizer Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 110. Pfizer Recent Development Table 111. GSK Company Details Table 112. GSK Business Overview Table 113. GSK Geriatric Medicines Product Table 114. GSK Revenue in Geriatric Medicines Business (2016-2021) & (US$ Million) Table 115. GSK Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Geriatric Medicines Market Share by Type: 2020 VS 2027 Figure 2. Analgesics Features Figure 3. Antihypertensives Features Figure 4. Statins Features Figure 5. Antidiabetics Features Figure 6. Proton Pump Inhibitor Features Figure 7. Anticoagulant Features Figure 8. Antipsychotics Features Figure 9. Antidepressants Features Figure 10. Global Geriatric Medicines Market Share by Application: 2020 VS 2027 Figure 11. Cardiovascular diseases Case Studies Figure 12. Arthritis Case Studies Figure 13. Neurological Disorders Case Studies Figure 14. Cancer Case Studies Figure 15. Osteoporosis Case Studies Figure 16. Respiratory Case Studies Figure 17. Geriatric Medicines Report Years Considered Figure 18. Global Geriatric Medicines Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 19. Global Geriatric Medicines Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 20. Global Geriatric Medicines Market Share by Regions: 2020 VS 2027 Figure 21. Global Geriatric Medicines Market Share by Regions (2022-2027) Figure 22. Global Geriatric Medicines Market Share by Players in 2020 Figure 23. Global Top Geriatric Medicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicines as of 2020 Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicines Revenue in 2020 Figure 25. Global Geriatric Medicines Revenue Market Share by Type (2016-2021) Figure 26. Global Geriatric Medicines Revenue Market Share by Type (2022-2027) Figure 27. North America Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. North America Geriatric Medicines Market Share by Type (2016-2027) Figure 29. North America Geriatric Medicines Market Share by Application (2016-2027) Figure 30. North America Geriatric Medicines Market Share by Country (2016-2027) Figure 31. United States Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Canada Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Europe Geriatric Medicines Market Share by Type (2016-2027) Figure 35. Europe Geriatric Medicines Market Share by Application (2016-2027) Figure 36. Europe Geriatric Medicines Market Share by Country (2016-2027) Figure 37. Germany Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. France Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. U.K. Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Italy Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Russia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Nordic Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Asia-Pacific Geriatric Medicines Market Share by Type (2016-2027) Figure 45. Asia-Pacific Geriatric Medicines Market Share by Application (2016-2027) Figure 46. Asia-Pacific Geriatric Medicines Market Share by Region (2016-2027) Figure 47. China Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Japan Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. South Korea Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Southeast Asia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. India Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Australia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Latin America Geriatric Medicines Market Share by Type (2016-2027) Figure 55. Latin America Geriatric Medicines Market Share by Application (2016-2027) Figure 56. Latin America Geriatric Medicines Market Share by Country (2016-2027) Figure 57. Mexico Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Brazil Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Middle East & Africa Geriatric Medicines Market Share by Type (2016-2027) Figure 61. Middle East & Africa Geriatric Medicines Market Share by Application (2016-2027) Figure 62. Middle East & Africa Geriatric Medicines Market Share by Country (2016-2027) Figure 63. Turkey Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Saudi Arabia Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. UAE Geriatric Medicines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 66. Eli Lilly and Company Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 67. AstraZeneca Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 68. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 69. Abbott Laboratories Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 70. Sanofi Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 72. Merck Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 73. Novartis Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 74. Pfizer Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 75. GSK Revenue Growth Rate in Geriatric Medicines Business (2016-2021) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Eli Lilly and Company AstraZeneca Boehringer Ingelheim Abbott Laboratories Sanofi Bristol-Myers Squibb Merck Novartis Pfizer GSK